112949 ⎘
Oligonucleotides characterized by their use Screening for pharmacological compounds
Cancer associated araf1 protein kinase and its uses
#3302PRO16090 antibodies
#3303Fibulin-3 and uses thereof
#3304Cardiac pressure overload associated genes
#3305Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc
#3306Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
#3307Methods and kits for detecting mutations
#3308Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods, and kits thereof
#3309Human delta-n p73 molecules and uses thereof
#3310Protein involved in cancer
#3311Therapy with enterotoxin to treat ovarian and uterine cancer
#3312Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3313Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3314THE PRO4979 POLYPEPTIDE
#3315Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3316Identifying agents for decreasing cellular toxicity associated with huntingin polypeptide
#3317Drug targets for the treatment of neurodegenerative disorders
#3318Surrogate markers of neuropathic pain
#3319Endocan compositions and methods for the treatment of neoplasms
#3320Methods for selecting treatment regimens and predicting outcomes in cancer patients
#3321Methods for identifying parkinson's disease therapeutics
#3322Methods for diagnosis and prognosis of cancer
#3323Murine genomic polynucleotide sequence encoding a G-protein coupled receptor and methods of use therefor
#3324PRO19624 antibodies
#3325PRO9835 antibodies
#3326Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3327Antibodies to PRO 1120 polypeptide
#3328Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3329Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3330Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3331Methods of assessing the risk for the development of sporadic prostate cancer
#3332Diagnosis and treatment of fanconi's anemia
#3333Screening methods for cognitive enhancers
#3334LEPROTL1 and OB-RGRP genes for screening compounds that act on the gain or loss of weight or on diabetes in a human or animal subject
#3335Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
#3336Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3337Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3338Cancer specific gene MH15
#3339Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3340Novel serine threonine kinase member, h2520-59
#3341Flj20647s as modifiers of the p21 pathway and methods of use
#3342Sulfatases and methods of use thereof
#3343MIFL- a new partner gene of MLL and methods of use thereof
#3344Outcome prediction and risk classification in childhood leukemia
#3345MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
#3346SENP1 as a marker of cancer development and target for cancer therapy
#3347Mutant met and uses therefor
#3348Compositions and methods for treatment of non-Hodgkin's lymphoma
#3349Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11)
#3350Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
#3351Detection, evaluation and treatment for advanced prostate cancer
#3352Methods of treating smooth muscle cell disorders
#3353Human Dickkopf-related nucleic acid molecules
#3354Administration of FGF2 for treamtent of anxiety
#3355Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3356Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3357Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3358Nucleic acid underexpressed in esophageal tumor
#3359Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3360Canine CYP1A2 genetic polymorphism
#3361Identification of polynucleotides and polypetide for predicting activity of compounds that interact with protein tyrosine kinase and or protein tyrosine kinase pathways
#3362XAF genes and polypeptides: methods and reagents for modulating apoptosis
#3363Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3364Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3365Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
#3366Marker at the androgen receptor gene for determining breast cancer susceptibility
#3367Method and compositions for treating diseases targeting CD71
#3368Method for identifying cellular growth inhibitors
#3369Necessary and sufficient reagent sets for chemogenomic analysis
#3370Aberrant kallikrein expression
#3371Genes involved in osteogenesis, and methods of use
#3372Prostate cancer diagnosis and outcome prediction by expression analysis
#3373Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3374Reagents and methods useful for detecting diseases of the breast
#3375Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
#3376Modulation of glucocorticoid receptor expression
#3377MLL translocations specify a distinct gene expression profile, distinguishing a unique leukemia
#3378Molecular analysis of hair follicles for disease
#3379Method for diagnosing non-small cell lung cancers
#3380Novel therapeutic targets in cancer
#3381Use of biomolecular targets in the treatment and visualization of brain tumors
#3382Molecular determinants of myeloma bone disease and uses thereof
#3383Polynucleotide encoding autoantigens associated with endometriosis
#3384Polynucleotide encoding autoantigens associated with endometriosis
#3385Interleukin-8 homologous polypeptides and therapeutic uses thereof
#3386Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3387Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in lung cancer cells
#3388Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
#3389Molecular markers of cisplatin resistance in cancer and uses thereof
#3390Compositions and methods for treating and diagnosing cancer
#3391Methods for altering mRNA splicing and treating familial dysautonomia and other mechanistically related disorders
#3392Diagnoses and therapeutics for cancer
#3393Use of Mrf-2 for screening and therapies
#3394PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use
#3395SENP1 as a marker for cancer
#3396Sensitivity test to predict efficacy of anti-cancer therapies
#3397Phage microarray profiling of the humoral response to disease
#3398Prostate cancer diagnosis and outcome prediction by expression analysis
#3399Human protein kinase, phosphatase, and protease family members and uses thereof
#3400Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3401Use of gene expression profiling to predict survival in cancer patient
#3402Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3403Methods and compositions for the diagnosis of Cornelia de Lange Syndrome
#3404Therapeutic polypeptides, nucleic acids encoding same, and methods of use
#3405Human mast cell-expressed membrane proteins
#3406Method for detecting the presence or risk of prostate cancer by detecting products of psa or klk2
#3407SNPs of apolipoprotein B and modulation of their expression
#3408Use of HLA-G genotyping in immune-mediated conditions
#3409Methods for detecting ovarian cancer
#3410Cancer-linked gene as target for chemotherapy
#3411Method to predict prostate cancer
#3412Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
#3413Gene expression profiling based identification of CKS1B as a potential therapeutic target in multiple myeloma
#3414Reagents and methods useful for detecting diseases of the urinary tract
#3415Gene imprinting and methylated CpG islands
#3416Methods for identifying subjects at risk of melanoma and treatments thereof
#3417EGFR mutations
#3418Method for treating synovial sarcoma
#3419Expression profiling in non-small cell lung cancer
#3420Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3421Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
#3422Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#3423Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
#3424Method for increasing synaptic growth or plasticity
#3425Identification of a novel endothelial-derived gene EG-1
#3426Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
#3427Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3428Reagents and methods useful for detecting diseases of the gastrointestinal tract
#3429Biomarkers for multiple sclerosis and methods of use thereof
#3430Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3431Novel tumor suppressor gene and compositions and methods for making and using the same
#3432Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
#3433Compositions and methods for diagnosing, preventing, and treating cancers
#3434Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer
#3435Methods of reducing microbial resistance to drugs
#3436Tumor suppressor gene
#3437Fra-1 expression in brain cancer
#3438Method for diagnosing pancreatic cancer
#3439Drug screening
#3440Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3441Differential drug sensitivity
#3442Oct-4 and GJIC expression as markers for adult human stem cells and cancer cell precursors
#3443Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3444Method for selecting a treatment for non-small cell lung cancer using gene expression profiles
#3445Reagents and methods useful for detecting diseases of the prostate
#3446Systems and methods for detecting and regulating metastasis
#3447ACE2 activation for treatment of heart, lung and kidney disease and hypertension
#3448Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
#3449Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
#3450Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3451Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents
#3452Assay systems and methods for detecting molecules that interact with SK2 channels
#3453PRO 1384 antibodies
#3454Modulation of transthyretin expression
#3455Identification of ligands by selective amplification of cells transfected with a 5HT2A receptor
#3456Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3457Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
#3458Diagnosis and treatment of disorders of collagen and elastin metabolism
#3459Modulation of STAT 6 expression
#3460Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer
#3461Use of Pin1 inhibitors for treatment of cancer
#3462Diagnosing predisposition to fat deposition and associated conditions
#3463Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
#3464Reagents and methods useful for detecting diseases of the prostate
#3465PPARdelta assay
#3466Methods and compositions for categorizing patients
#3467Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)
#3468Methods for identifying risk of melanoma and treatments thereof
#3469Method for identifying myelodysplastic syndrome-specific genes
#3470Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
#3471Method for assaying susceptibility to cancer therapy in a subject by assaying for tumors of P53
#3472Gene products differentially expressed in cancerous cells and their methods of use II
#3473Alternatively spliced isoforms of sodium channel, voltage gated, type XI, alpha (SCN11A)
#3474Biomarker:compound correlations in cancer diagnosis and therapy
#3475Reagents and methods for identifying and modulating expression of genes regulated by retinoids
#3476Map3ks as modifiers of the p53 pathway and methods of use
#3477YKL-40 as a marker and prognostic indicator for cancers
#3478Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
#3479Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid
#3480Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3481Method for identifying immunoreactive peptides
#3482Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
#3483Cancer-linked gene as target for chemotherapy
#3484Cancer associated protein kinases and their uses
#3485Reagents and methods useful for detecting diseases of the breast
#3486Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3487Identification of cancer protein biomarkers using proteomic techniques
#3488Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3489Methods for identifying risk of breast cancer and treatments thereof
#3490Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
#3491Reagents and methods useful for detecting diseases of the prostate
#349229 human cancer associated proteins
#3493Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds
#3494Testing endosymbiont cellular organelles and compounds identifiable therewith
#3495RBP4 in insulin sensitivity/resistance, diabetes, and obesity
#3496Full-length expressed genetic markers
#3497Compositions and methods for the diagnosis and treatment of tumor
#3498Determining the chemosensitivity of cells to cytotoxic agents
#3499Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
#3500Brca-1 regulators and methods of use
#3501Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
#3502Reagents and methods useful for detecting diseases of the breast
#3503Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3504Methods of screening for LTRPC2 modulators
#3505Thymidylate synthase gene and metastasis
#3506Methods for identification, assessment, prevention, and therapy of cancer
#3507Novel therapeutic targets in cancer
#3508Compositions and methods for prognosis of cancers
#3509Methods for diagnosing and treating bladder cancer
#3510Human Type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
#3511Methods for identifying risk of breast cancer and treatments thereof
#3512Reagents and methods useful for detecting diseases of the breast
#3513RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
#3514Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3515Aberrant Myc/TIP60 interactions as a target for anti-cancer therapeutics
#3516B-raf polynucleotides
#3517Diagnosis and prevention of cancer cell invasion
#3518PRMTs as modifiers of the p53 pathway and methods of use
#3519Compositions and methods relating to ovary specific genes and proteins
#3520Reagents and methods useful for detecting diseases of the prostate
#3521Modulation of eIF4E-BP1 expression
#3522Targeted cancer therapy
#3523Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer
#3524Kruppel-like factor 6 ( KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein
#3525Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer
#3526Diagnostic markers of mood disorders and methods of use thereof
#3527Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3528Macrophage migration inhibitory factor (MIF) as marker for urological inflammatory disease
#3529Methods for diagnosing and treating diseases and conditions associated with protein kinase Cλ
#3530Reagents and methods useful for detecting diseases of the gastrointestinal tract
#3531Reagents and methods useful for detecting diseases of the lung
#3532Reagents and methods useful for detecting diseases of the urinary tract
#3533Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3534Secreted and transmembrane polypetides and nucleic acids encoding the same
#3535Method of diagnosing, monitoring, staging, imaging and treating breast cancer
#3536Modulation of glucocorticoid receptor expression
#3537Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3538Compositions and methods for the diagnosis and treatment of tumor
#3539Methods to predict patient responsiveness to tyrosine kinase inhibitors
#3540Molecular diagnosis and prognosis of carcinomas
#3541Development of DNA probes and immunological reagents specific for cell surface-expressed molecules and transformation-associated genes
#3542Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
#3543PG-3 and biallelic markers thereof
#3544Methods for the early diagnosis of ovarian cancer
#3545Reagents and methods useful for detecting diseases of the gastrointestinal tract
#3546EGR genes as targets for the diagnosis and treatment of schizophrenia
#3547Diagnostic and therapeutic uses of SUFU gene
#3548Methods for assaying gene imprinting and methylated cpg islands
#3549Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3550Reagents and methods useful for detecting diseases of the breast
#3551Cancer specific gene MG20
#3552Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3553Method of diagnosing, monitoring, staging, imaging and treating colon cancer
#3554Differential gene expression in intestinal polyps
#3555Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
#3556Method of analyzing gene expression
#3557Method of diagnosing, monitoring, staging, imaging and treating cancer
#355814-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
#3559Methods of identifying inverse agonists of the serotonin 2A receptor
#3560Tumor suppressor designated TS10q23.3
#3561Methods and compositions for diagnosing and suppressing metastasis thereof
#3562Breast cancer associated polypeptide
#3563Method of identifying compounds that induce cell death by necrosis
#3564Gene segregation and biological sample classification methods
#3565Compositions, splice variants and methods relating to lung specific nucleic acids and proteins
#3566Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3567Dectection of AMACR cancer markers in urine
#3568Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3569Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
#3570Animal model for the analysis of tumor metastasis
#3571HX2004-6 polypeptide expressed in cancerous cells
#3572Identification and verification of methylation marker sequences
#3573Methods for diagnosis of cardiovascular disease
#3574Knockout mouse for the tumor suppressor gene ANX7
#3575Assay and treatment
#3576Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders
#3577Screening system for modulators of her2 mediated transcription and her2 modulators identified thereby
#3578Full-length prostate selective polynucleotides and polypeptides
#3579Compositions and methods for diagnosing and treating cancers
#3580Secreted and transmembrane polypeptides and nucleic acids encoding the same
#3581Methods for identifying risk of breast cancer and treatments thereof
#3582Modulation of line-1 reverse transcriptase
#3583Gene amplification and overexpression in cancer
#3584Methods for predicting relative efficacy of a beta blocker therapy based on a B1-adrenergic receptor polymorphism
#3585Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
#3586Compositions and methods for the diagnosis and treatment of tumors of glial origin
#3587Reagents and methods useful for detecting diseases of the prostate
#3588Methods and compositions for detecting colon cancers
#3589Method of diagnosing, monitoring, staging, imaging and treating colon cancer
#3590Nucleic acid sequences and methods for identifying compounds that affect RNA/RNA binding protein interactions and mRNA functionality
#3591Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer
#3592MUC17 encoding nucleic acid sequences, polypeptides, antibodies and methods of use thereof
#3593NFAT transcription factors in tumor progression
#3594Methods of using CRCA-1 as a stomach and esophageal cancer marker
#3595Targets for hepatitis C virus infections
#3596T cell regulatory genes associated with immune disease
#3597Identification of ovarian cancer tumor markers and therapeutic targets
#3598Immunogenic ovarian cancer genes
#3599Therapeutic targets in cancer
#3600Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders